Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of April 6, 2026, InspireMD Inc. (NSPR), a medical technology company focused on cardiovascular care solutions, is trading at a current price of $1.49, marking a 3.25% decline in recent trading sessions. This analysis breaks down the key market context, technical indicators, and potential near-term scenarios for NSPR, to provide market participants with a clear overview of the stock’s current positioning. No recent earnings data is available for the company as of this analysis, with its next
Is InspireMD (NSPR) Stock Overpriced Now | Price at $1.49, Down 3.25% - Community Risk Signals
NSPR - Stock Analysis
4077 Comments
944 Likes
1
Izena
Power User
2 hours ago
I bow down to your genius. 🙇♂️
👍 36
Reply
2
Elizabet
Insight Reader
5 hours ago
Would’ve made a different call if I saw this earlier.
👍 116
Reply
3
Chevella
Expert Member
1 day ago
I didn’t even know this existed until now.
👍 92
Reply
4
Maclaren
Active Reader
1 day ago
This feels like I should apologize.
👍 222
Reply
5
Minton
Active Contributor
2 days ago
Missed the chance… again. 😓
👍 162
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.